Demyelinating disorders

Clinical trials for Demyelinating disorders explained in plain language.

Never miss a new study

Get alerted when new Demyelinating disorders trials appear

Sign up with your email to follow new studies for Demyelinating disorders, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Exploring the utility of [18F]3F4AP for demyelination imaging

Recruiting now

The overall objective is to obtain an assessment of the pharmacokinetics of \[18F\]3F4AP in healthy volunteers and subjects with demyelinating diseases such as mild cognitive impairment (MCI), Alzheimer's Disease (AD), Multiple Sclerosis (MS), Spinal Cord Injury (SCI) and Spinal …

Matched conditions: DEMYELINATING DISORDERS

Phase 1 • Sponsor: Yale University

Last updated Sep 09, 2026 15:00 UTC

Demyelinating disorders

Get alerted when new Demyelinating disorders trials appear

Exploring the utility of [18F]3F4AP for demyelination imaging